Generic Pharmaceuticals Global Market Opportunities And Strategies To 2030: COVID-19 Impact And Recovery
Generic Pharmaceuticals Global Market Opportunities And Strategies To 2030: COVID-19 Impact And Recovery from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global generic pharmaceuticals market as it emerges from the COVID 19 shut down.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 12 geographies.
- Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market research findings.
- Benchmark performance against key competitors.
- Utilize the relationships between key data sets for superior strategizing.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Where is the largest and fastest growing market for the generic pharmaceuticals? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The generic pharmaceuticals market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider generic pharmaceuticals market; and compares it with other markets.
The report covers the following chapters
Executive Summary – The executive summary section of the report gives a brief overview and summary of the report
Report Structure – This section gives the structure of the report and the information covered in the various sections.
Introduction – The introduction section of the report gives brief introduction about segmentation by geography, segmentation by therapy, segmentation by distribution channel, and segmentation by type, and by drug delivery.
Market Characteristics – The market characteristics section of the report defines and explains the electric commercial vehicles market. This chapter also defines and describes goods and related services covered in the report.
Trends And Strategies – This chapter describes the major trends shaping the global generic pharmaceutical market. This section highlights likely future developments in the market and suggests approaches companies can take to exploit these opportunities.
COVID-19 Impact – This chapter describes the impact that the COVID-19 pandemic had across various industries and companies in the generic pharmaceutical industry.
Global Market Size And Growth – This section contains the global historic (2015-2020) and forecast (2025F, 2030F) market values, and drivers and restraints that support and restrain the growth of the market in the historic and forecast periods.
Regional Analysis – This section contains the historic (2015-2020), forecast (2020-2025F, 2030F) market value and growth and market share comparison by region.
Segmentation – This section contains the market values (2015-2020, 2025F, 2030F) and analysis for different segments in the market.
Regional Market Size And Growth – This section contains the region’s market size (2020), historic and forecast (2015-2025, 2030F) market values, and growth and market share comparison of major countries within the region. This report includes information on all the regions (Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa).
Competitive Landscape – This section covers details on the competitive landscape of the global generic pharmaceutical market, estimated market shares and company profiles of the leading players.
Key Mergers And Acquisitions – This chapter gives the information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
Market Opportunities And Strategies– This section includes market opportunities and strategies based on findings of the research. This section also gives information on growth opportunities across countries, segments and strategies to be followed in those markets. It gives an understanding of where there is significant business to be gained by competitors in the next five years.
Recommendations – This section includes conclusions and recommendations based on findings of the research. This section also gives recommendations for generic pharmaceuticals in terms of product offerings, geographic expansion, marketing strategies and target groups.
Appendix – This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.
Scope
Markets Covered: 1) By Therapy: CNS; Cardiovascular; Dermatology; Genitourinary/Harmonal; Respiratory; Rheumatology; Diabetes; Oncology; Biosimilars; Others
2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
3) By Type: Biosimilars; Generics
4) By Drug Delivery: Oral; Injectables; Dermal/Topical; Inhalers
Companies Mentioned: Teva Pharmaceutical Industries Ltd.; Novartis AG; Sun Pharmaceutical Industries Ltd.; Fresenius Kabi; Aurobindo Pharma Limited
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; generic pharmaceutical indicators comparison.
Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- 1. Generic Pharmaceuticals Market Executive Summary
- 2. Table of Contents
- 3. List of Figures
- 4. List of Tables
- 5. Report Structure
- 6. Introduction
- 6.1. Segmentation By Geography
- 6.2. Segmentation By Therapy
- 6.3. Segmentation By Distribution Channel
- 6.4. Segmentation By Type
- 6.5. Segmentation By Drug Delivery
- 7. Generic Pharmaceuticals Market Characteristics
- 7.1. Segmentation By Therapy
- 7.1.1. CNS
- 7.1.2. Cardiovascular
- 7.1.3. Dermatology
- 7.1.4. Genitourinary/Harmonal
- 7.1.5. Respiratory
- 7.1.6. Rheumatology
- 7.1.7. Diabetes
- 7.1.8. Oncology
- 7.1.9. Biosimilars
- 7.1.10. Others
- 7.2. Segmentation By Distribution Channel
- 7.2.1. Hospital Pharmacies
- 7.2.2. Retail Pharmacies
- 7.2.3. Online Pharmacies
- 7.3. Segmentation By Type
- 7.3.1. Biosimilar
- 7.3.2. Generics
- 7.4. Segmentation By Drug Delivery Method
- 7.4.1. Oral
- 7.4.2. Injectables
- 7.4.3. Dermal/Topical
- 7.4.4. Inhaled
- 8. Generic Pharmaceuticals Market Trends And Strategies
- 8.1. Use of Biomarkers for Drug Development
- 8.2. New Product Launches
- 8.3. Investment in Artificial Intelligence
- 8.4. Collaboration Driving Innovation
- 8.5. Combination Drug Therapy
- 8.6. 3D Printing Technology
- 8.7. Modification Of Existing Epilepsy Drugs
- 8.8. Rise Of Generic Respiratory Drugs
- 9. Impact Of COVID-19 On Generic Pharmaceuticals Market
- 9.1. Introduction
- 9.2. Impact Of COVID-19 on Supply Chain Issues
- 9.3. Impact Of COVID-19 Leading To Induced Demand And Panic Buying
- 9.4. Impact Of COVID-19 On Companies
- 9.5. Future Outlook
- 10. Global Generic Pharmaceuticals Market Size And Growth
- 10.1. Market Size
- 10.2. Historic Market Growth, 2015 – 2020, Value ($ Million)
- 10.2.1. Drivers Of The Market 2015 – 2020
- 10.2.2. Restraints On The Market 2015 – 2020
- 10.3.Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)
- 10.3.1. Drivers Of The Market 2020 – 2025
- 10.3.2. Restraints On The Market 2020 – 2025
- 11. Global Generic Pharmaceuticals Market Segmentation
- 11.1. Global Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 11.2. Global Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 11.3. Global Generic Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 11.4.Global Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 12. Generic Pharmaceuticals Market, Regional And Country Analysis
- 12.1. Global Generic Pharmaceuticals Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 12.2. Global Generic Pharmaceuticals Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 13. Asia-Pacific Generic Pharmaceuticals Market
- 13.1. Asia-Pacific Generic Pharmaceuticals Market Overview
- 13.1.1. Region Information
- 13.1.2. Market Information
- 13.1.3. Background Information
- 13.1.4. Government Initiatives
- 13.1.5. Regulations
- 13.1.6. Regulatory Bodies
- 13.1.7. Major Associations
- 13.1.8. Taxes Levied
- 13.1.9. Corporate Tax Structure
- 13.1.10. Investments
- 13.1.11. Major Companies
- 13.2. Asia-Pacific Generic Pharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
- 13.3. Asia-Pacific Generic Pharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)
- 13.4.Asia-Pacific Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 13.5. Asia-Pacific Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 13.6.Asia-Pacific Generic Pharmaceuticals Market: Country Analysis
- 13.7. China Generic Pharmaceuticals Market
- 13.8.China Generic Pharmaceuticals Market Overview
- 13.8.1. Country Information
- 13.8.2. Market Information
- 13.8.3. Background Information
- 13.8.4. Government Initiatives
- 13.8.5. Regulations
- 13.8.6. Regulatory Bodies
- 13.8.7. Major Associations
- 13.8.8. Taxes Levied
- 13.8.9. Corporate Tax Structure
- 13.8.10. Investments
- 13.8.11. Major Companies
- 13.9.China Generic Pharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
- 13.10. China Generic Pharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)
- 13.11. China Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 13.12. China Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 13.13. India Generic Pharmaceuticals Market
- 13.14. India Generic Pharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
- 13.15. India Generic Pharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)
- 13.16. India Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 13.17. India Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 13.18. Japan Generic Pharmaceuticals Market
- 13.19. Japan Generic Pharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
- 13.20. Japan Generic Pharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)
- 13.21. Japan Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 13.22. Japan Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 13.23. Australia Generic Pharmaceuticals Market
- 13.24. Australia Generic Pharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
- 13.25. Australia Generic Pharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)
- 13.26. Australia Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 13.27. Australia Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 13.28. Indonesia Generic Pharmaceuticals Market
- 13.29. Indonesia Generic Pharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
- 13.30. Indonesia Generic Pharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)
- 13.31. Indonesia Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 13.32. Indonesia Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 13.33. South Korea Generic Pharmaceuticals Market
- 13.34. South Korea Generic Pharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
- 13.35. South Korea Generic Pharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)
- 13.36. South Korea Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 13.37. South Korea Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 14. Western Europe Generic Pharmaceuticals Market
- 14.1.Western Europe Generic Pharmaceuticals Market Overview
- 14.1.1. Region Information
- 14.1.2. Market Information
- 14.1.3. Background Information
- 14.1.4. Government Initiatives
- 14.1.5. Regulations
- 14.1.6. Regulatory Bodies
- 14.1.7. Major Associations
- 14.1.8. Taxes Levied
- 14.1.9. Corporate Tax Structure
- 14.1.10. Investments
- 14.1.11. Major Companies
- 14.2. Western Europe Generic Pharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
- 14.3.Western Europe Generic Pharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)
- 14.4. Western Europe Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 14.5. Western Europe Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 14.6. Western Europe Generic Pharmaceuticals Market: Country Analysis
- 14.7. UK Generic Pharmaceuticals Market
- 14.8. UK Generic Pharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
- 14.9. UK Generic Pharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)
- 14.10. UK Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 14.11. UK Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 14.12. Germany Generic Pharmaceuticals Market
- 14.13. Germany Generic Pharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
- 14.14. Germany Generic Pharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)
- 14.15. Germany Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 14.16. Germany Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 14.17. France Generic Pharmaceuticals Market
- 14.18. France Generic Pharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
- 14.19. France Generic Pharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)
- 14.20. France Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 14.21. France Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 15. Eastern Europe Generic Pharmaceuticals Market
- 15.1. Eastern Europe Generic Pharmaceuticals Market Overview
- 15.1.1. Region Information
- 15.1.2. Market Information
- 15.1.3. Background Information
- 15.1.4. Government Initiatives
- 15.1.5. Regulations
- 15.1.6. Regulatory Bodies
- 15.1.7. Major Associations
- 15.1.8. Taxes Levied
- 15.1.9. Corporate Tax Structure
- 15.1.10. Investments
- 15.1.11. Major Companies
- 15.2. Eastern Europe Generic Pharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
- 15.3. Eastern Europe Generic Pharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)
- 15.4. Eastern Europe Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 15.5. Eastern Europe Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 15.6. Eastern Europe Generic Pharmaceuticals Market: Country Analysis
- 15.7. Russia Generic Pharmaceuticals Market
- 15.8. Russia Generic Pharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
- 15.9. Russia Generic Pharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)
- 15.10. Russia Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 15.11. Russia Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 16. North America Generic Pharmaceuticals Market
- 16.1.North America Generic Pharmaceuticals Market Overview
- 16.1.1. Region Information
- 16.1.2. Market Information
- 16.1.3. Background Information
- 16.1.4. Government Initiatives
- 16.1.5. Regulations
- 16.1.6. Regulatory Bodies
- 16.1.7. Major Associations
- 16.1.8. Taxes Levied
- 16.1.9. Corporate Tax Structure
- 16.1.10. Investments
- 16.1.11. Major Companies
- 16.2. North America Generic Pharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
- 16.3.North America Generic Pharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)
- 16.4. North America Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 16.5. North America Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 16.6. North America Generic Pharmaceuticals Market: Country Analysis
- 16.7. USA Generic Pharmaceuticals Market
- 16.8. USA Generic Pharmaceuticals Market Overview
- 16.8.1. Country Information
- 16.8.2. Market Information
- 16.8.3. Background Information
- 16.8.4. Government Initiatives
- 16.8.5. Regulations
- 16.8.6. Regulatory Bodies
- 16.8.7. Major Associations
- 16.8.8. Taxes Levied
- 16.8.9. Corporate Tax Structure
- 16.8.10.Investments
- 16.8.11. Major Companies
- 16.9. USA Generic Pharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
- 16.10. USA Generic Pharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)
- 16.11. USA Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 16.12. USA Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 17. South America Generic Pharmaceuticals Market
- 17.1. South America Generic Pharmaceuticals Market Overview
- 17.1.1. Region Information
- 17.1.2. Market Information
- 17.1.3. Background Information
- 17.1.4. Government Initiatives
- 17.1.5. Regulations
- 17.1.6. Regulatory Bodies
- 17.1.7. Major Associations
- 17.1.8. Taxes Levied
- 17.1.9. Corporate Tax Structure
- 17.1.10. Investments
- 17.1.11. Major Companies
- 17.2. South America Generic Pharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
- 17.3. South America Generic Pharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)
- 17.4. South America Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 17.5. South America Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 17.6. South America Generic Pharmaceuticals Market: Country Analysis
- 17.7. Brazil Generic Pharmaceuticals Market
- 17.8. Brazil Generic Pharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
- 17.9. Brazil Generic Pharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)
- 17.10. Brazil Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 17.11. Brazil Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 18. Middle East Generic Pharmaceuticals Market
- 18.1. Middle East Generic Pharmaceuticals Market Overview
- 18.1.1. Region Information
- 18.1.2. Market Information
- 18.1.3. Background Information
- 18.1.4. Government Initiatives
- 18.1.5. Regulations
- 18.1.6. Regulatory Bodies
- 18.1.7. Major Associations
- 18.1.8. Taxes Levied
- 18.1.9. Corporate Tax Structure
- 18.1.10. Investments
- 18.1.11. Major Companies
- 18.2. Middle East Generic Pharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
- 18.3.Middle East Generic Pharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)
- 18.4. Middle East Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 18.5. Middle East Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 19. Africa Generic Pharmaceuticals Market
- 19.1.Africa Generic Pharmaceuticals Market Overview
- 19.1.1. Region Information
- 19.1.2. Market Information
- 19.1.3. Background Information
- 19.1.4. Government Initiatives
- 19.1.5. Regulations
- 19.1.6. Regulatory Bodies
- 19.1.7. Major Associations
- 19.1.8. Taxes levied
- 19.1.9. Corporate Tax Structure
- 19.1.10. Investments
- 19.1.11. Major Companies
- 19.2. Africa Generic Pharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
- 19.3.Africa Generic Pharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)
- 19.4. Africa Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 19.5. Africa Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 20. Generic Pharmaceuticals Global Market Competitive Landscape
- 20.1. Company Profiles
- 20.2. Teva Pharmaceutical Industries Ltd.
- 20.2.1. Company Overview
- 20.2.2. Products And Services
- 20.2.3. Business Strategy
- 20.2.4. Financial Overview
- 20.3. Novartis AG
- 20.3.1. Company Overview
- 20.3.2. Products And Services
- 20.3.3. Business Strategy
- 20.3.4. Financial Overview
- 20.4. Viatris Inc.
- 20.4.1. Company Overview
- 20.4.2. Products And Services
- 20.4.3. Business Strategy
- 20.4.4. Financial Overview
- 20.5. Sun Pharmaceutical Industries Ltd.
- 20.5.1. Company Overview
- 20.5.2. Products And Services
- 20.5.3. Business Strategy
- 20.5.4. Financial Overview
- 20.6. Fresenius Kabi
- 20.6.1. Company Overview
- 20.6.2. Products And Services
- 20.6.3. Business Strategy
- 20.6.4. Financial Overview
- 21. Key Mergers And Acquisitions In The Generic Pharmaceuticals Market
- 21.1. Carlyle Acquired Viyash Life Sciences
- 21.2. Sandoz Acquired GSK’s Cephalosporin Antibiotics Business
- 21.3. ANI Pharmaceuticals, Inc. Acquired Novitium Pharma
- 21.4. Mylan NV Merged With Viatris
- 21.5. Sun Pharmaceutical Industries Acquired Aquinox Pharmaceuticals Inc.
- 21.6. ANI Pharmaceuticals, Inc. Acquired Amerigen Pharmaceuticals, Ltd. Generic Products
- 21.7. Sandoz Acquired Aspen Global Incorporated (AGI)
- 21.8. Teva Pharmaceutical Industries Ltd. Acquired Allergan plc
- 21.9. Sun Pharma Acquired Ranbaxy Laboratories
- 21.10. Pfizer Inc. Merged With Hospira, Inc.
- 22. Generic Pharmaceuticals Market Future Outlook and Potential Analysis
- 22.1. Global Generic Pharmaceuticals Market In 2025 – Countries Offering Most New Opportunities
- 22.2. Global Generic Pharmaceuticals Market In 2025 – Segments Offering Most New Opportunities
- 22.3. Global Generic Pharmaceuticals Market In 2025 – Growth Strategies
- 22.3.1. Market Trend Based Strategies
- 22.3.2. Competitor Strategies
- 23. Appendix
- 23.1. Market Data Sources
- 23.2. NAICS Definitions Of Industry Covered In This Report
- 23.3.Research Methodology
- 23.4. Abbreviations
- 23.5. Currencies
- 23.6. Research Inquiries
- 23.7. The Business Research Company
- 23.8. Copyright And Disclaimer
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook